Works by NIANHAI LIANG
Results: 3
SPRY4 inhibits and sensitizes the primary KIT mutants in gastrointestinal stromal tumors (GISTs) to imatinib.
- Published in:
- Gastric Cancer, 2023, v. 26, n. 5, p. 677, doi. 10.1007/s10120-023-01402-4
- By:
- Publication type:
- Article
MiR-19a-3p Promotes Aerobic Glycolysis in Ovarian Cancer Cells via IGFBP3/PI3K/AKT Pathway.
- Published in:
- Folia Biologica (00155500), 2023, v. 69, n. 5/6, p. 163, doi. 10.14712/fb2023069050163
- By:
- Publication type:
- Article
MiR-194-5p suppresses the warburg effect in ovarian cancer cells through the IGF1R/PI3K/AKT axis.
- Published in:
- Biocell, 2023, v. 47, n. 3, p. 547, doi. 10.32604/biocell.2023.025048
- By:
- Publication type:
- Article